0001209191-20-035031.txt : 20200608
0001209191-20-035031.hdr.sgml : 20200608
20200608172835
ACCESSION NUMBER: 0001209191-20-035031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200604
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Powell Andrew Kenneth William
CENTRAL INDEX KEY: 0001304113
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 20950111
MAIL ADDRESS:
STREET 1: C/O COLLAGENEX PHARMACEUTICALS, INC.
STREET 2: 41 UNIVERSITY DRIVE
CITY: NEWTOWN
STATE: PA
ZIP: 18940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-04
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001304113
Powell Andrew Kenneth William
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE
PA
19087
1
0
0
0
Common Stock
2020-06-06
4
M
0
7333
A
16709
D
Option Grant (right to buy)
1.41
2020-06-04
4
A
0
16500
0.00
A
2030-06-03
Common Stock
16500
16500
D
Restricted Stock Units
2020-06-06
4
M
0
7333
0.00
D
Common Stock
7333
0
D
Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
The shares subject this option will vest in twelve equal monthly installments commencing July 4, 2020, subject to Reporting Person's continuous service through each such date.
This grant was made pursuant to the issuer's amended and restated non-employee director compensation policy.
The shares underlying these restricted stock units vested on June 6, 2020.
/s/ Mark Ballantyne, Attorney-in-fact
2020-06-08